ANTABUSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Antabuse, and when can generic versions of Antabuse launch?
Antabuse is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.
The generic ingredient in ANTABUSE is disulfiram. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Antabuse
A generic version of ANTABUSE was approved as disulfiram by SIGMAPHARM LABS LLC on March 28th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ANTABUSE?
- What are the global sales for ANTABUSE?
- What is Average Wholesale Price for ANTABUSE?
Summary for ANTABUSE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 99 |
| Clinical Trials: | 27 |
| Patent Applications: | 3,345 |
| DailyMed Link: | ANTABUSE at DailyMed |
Recent Clinical Trials for ANTABUSE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | EARLY_PHASE1 |
| Columbia University | EARLY_PHASE1 |
| University of Rochester | PHASE1 |
US Patents and Regulatory Information for ANTABUSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088482-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Odyssey Pharms | ANTABUSE | disulfiram | TABLET;ORAL | 088483-001 | Dec 8, 1983 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Womens | ANTABUSE | disulfiram | TABLET;ORAL | 007883-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
